Core Facility Monoclonal Antibodies

Aims: To develop well-validated custom-designed monoclonal antibodies for research, diagnostics and therapy. 

  • Development of antibodies with diagnostic and immunotherapeutic potential in cancer therapy, diabetes, neurodegenerative disorders and other diseases;
  • Development of diagnostic antibody arrays based on proprietary antibodies targeting extracellular vesicles from cancer and diabetic patients;
  • Antibodies specific for nucleic acid modifications involved in the regulation of transcription, translation and epigenetic inheritance.

Please see:
Monoclonal Antibodies Core Facility